Back

Differential TDP-43 interactomes between the cortex and cerebellum in the mouse

Baldacchino, T.; Lynham, S.; Tacconelli, S.; Vance, C.; Mitchell, J. C.

2026-01-16 neuroscience
10.64898/2026.01.16.699854 bioRxiv
Show abstract

TAR DNA binding protein 43 (TDP-43) is the core pathogenic protein across a spectrum of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) cases, but its pathological deposition shows regional selectivity, with abundant TDP-43 positive aggregates in the frontal cortex and spinal cord, and a much lower burden in the cerebellum. In health, TDP-43 expression in the cerebellum is higher than in cortex, hence what underpins this differential vulnerability to TDP-43 aggregation is unclear. Here we demonstrate that in healthy C57Bl/6J mice not only is TDP-43 expression higher in the cerebellum than the cortex, but that this expression difference is driven primarily by differences in cytoplasmic load. Mass spectrometry analysis of TDP-43 pull downs from the cortex and cerebellum of healthy mice identified TDP-43 interactors across a number of core functional pathways, with numerous differences between the two brain regions. Data are available via ProteomeXchange with identifier PXD062532. Notably, there were more interactors identified in both nuclear and cytoplasmic fractions within the cortex than the cerebellum. Putative interactions with four core paraspeckle proteins; SFPQ, NONO, FUS and PSPC1 were confirmed using immunoprecipitation and western blot analysis. Follow up validation using proximity ligation assay showed abundant perinuclear cytoplasmic interactions between TDP-43 and all four paraspeckle proteins in both large motor cortex neurons and purkinje cells, with significantly reduced nuclear interactions detected in the motor cortex for SFPQ, FUS and PSPC1. These findings suggest that TDP-43-protein interactions markedly differ between the TDP-43 pathogenesis vulnerable cortex and relatively resistant cerebellum and exploring these differences may yield new insight into disease mechanisms within ALS/FTD.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Neurobiology of Disease
134 papers in training set
Top 0.1%
18.4%
2
Molecular Neurodegeneration
49 papers in training set
Top 0.1%
14.2%
3
Acta Neuropathologica
51 papers in training set
Top 0.1%
12.4%
4
Acta Neuropathologica Communications
81 papers in training set
Top 0.1%
9.0%
50% of probability mass above
5
Brain
154 papers in training set
Top 0.9%
6.3%
6
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.1%
6.3%
7
Annals of Neurology
57 papers in training set
Top 0.9%
2.1%
8
Alzheimer's & Dementia
143 papers in training set
Top 2%
2.1%
9
Scientific Reports
3102 papers in training set
Top 54%
1.9%
10
Brain Communications
147 papers in training set
Top 2%
1.5%
11
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.5%
12
Nature Communications
4913 papers in training set
Top 55%
1.3%
13
Cell Reports
1338 papers in training set
Top 28%
1.2%
14
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.9%
0.9%
15
Frontiers in Molecular Neuroscience
43 papers in training set
Top 0.8%
0.8%
16
Human Molecular Genetics
130 papers in training set
Top 3%
0.8%
17
eLife
5422 papers in training set
Top 58%
0.7%
18
PLOS ONE
4510 papers in training set
Top 68%
0.7%
19
npj Parkinson's Disease
89 papers in training set
Top 1%
0.7%
20
Frontiers in Neurology
91 papers in training set
Top 5%
0.7%
21
The Journal of Pathology
22 papers in training set
Top 0.6%
0.7%
22
eneuro
389 papers in training set
Top 10%
0.6%